Advanced Search
DSpace@MIT

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)

Research and Teaching Output of the MIT Community

Files in this item

Name Size Format
Downloadable Full Text - PDF

This item appears in the following Collection(s)

Creative Commons Attribution-NonCommercial-NoDerivs License Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial-NoDerivs License
Open Access